Primary CNS lymphomas are uncommon tumors in immunocompetent patients. We describe the radiological features that should orient towards performing a biopsy and analyze the results in our series of patients.
Methods
We reviewed 22 immunocompetent patients with primary central nervous system lymphoma admitted in our Institute between 1977 and 1997. The follow-up period ranged from 2 months (patient deceased) to 69 months. Fourteen patients underwent surgical removal of the tumor and the remainder a biopsy. All patients received radiotherapy and 8 patients radiotherapy plus chemotherapy.
Results
Two of the 14 patients treated by surgical removal of the tumor died. There was no mortality related to biopsy procedures. Patients treated with radiotherapy had 1-year, 2-year and 5-year survival rates of 66%, 41.6% and 16.6%, compared to 87.5%, 62.5% and 50%, respectively, for patients who received radiotherapy and chemotherapy.
Conclusions
At present, there is no definite treatment for these highly malignant brain tumors. The most favorable results seem related to biopsy followed by radiotherapy plus chemotherapy versus surgical removal, which is related to a high risk of severe postoperative deficit for both the deep location and infiltrating nature of these lesions.
JellingerK., RadaskiewczT., SlowickF.: Primary malignant lymphomas of the central nervous system. Acta Neuropathol (Suppl) (Berl), 6: 95–102, 1975.
3.
O'NeillB.P., KellyP.J., EarleJ.D., ScheithauerB., BanksP.M.: Computer-assisted stereotaxic biopsy for the diagnosis of primary central nervous system lymphoma. Neurology, 37: 1160–1164, 1987.
4.
MorgelloS., MaieseK., PetitoC.K.: T-cell lymphoma in the CNS: clinical and pathologic features. Neurology, 39: 1190–1196, 1989.
5.
FreemanC., BergJ.W., CutlerS.J.: Occurrence and prognosis of extranodal lymphomas. Cancer, 29: 252–260, 1972.
6.
JellingerK., SlowikF., SlugaE.: Primary intracranial malignant lymphomas. A fine structural, cytochemical and CSF immunological study. Clin Neurol Neurosurg, 83: 173–186, 1979.
7.
WoofdmanR., ShinK., PineoG.: Primary non-Hodgkin's lymphoma of the brain. Medicine, 64: 425–430, 1985.
8.
BednarM.M., SalerniA., FlanaganM.E., PendleburyW.W.: Primary central nervous system T-cell lymphoma. Case report. J Neurosurg, 74: 668–672, 1991.
9.
BerryM.P., SimpsonW.J.: Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Radiat Oncol Biol Phys, 7: 55–59, 1981.
10.
JungR.C., HowserD.M., AndersonT., FisherR.I., JaffeE., De VitaV.T.: Central nervous system complications of non-Hodgkin's lymphoma: the potential role for prophylactic therapy. Am J Med, 66: 435–443, 1979.
SoYt, BecksteadJ.H., DavisR.L.: Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathologic study. Ann Neurol, 20: 566–572, 1986.
13.
GonzalesD.G., Schuster-UitterhoeveL.J.: Primary non-Hodgkin's lymphoma of the central nervous system. Results of radiotherapy in 15 cases. Cancer, 51: 2048–2052, 1983.
14.
HochbergF.H., MillerD.C.: Primary central nervous system lymphoma. J Neurosurg, 68: 835–853, 1988.
15.
LittmanP., WangC.C.: Reticulum cell sarcoma of the brain. A review of the literature and a study of 19 cases. Cancer, 35: 1412–1420, 1975.
16.
MurrayK., KunL., CoxJ.: Primary malignant lymphoma of the central nervous system, result of treatment of 11 cases and review of the literature. J Neursosurg, 65: 600–607, 1986.
ReicheW., DeinzerM.: Neuroradiologic diagnosis of primary non-Hodgkin's lymphoma of the brain. Radiologe, 38: 913–923, 1998.
30.
VaqueroJ., MartinezR., RossiE., LopezR.: Primary cerebral lymphoma: the “ghost tumor”. Case report. J Neurosurg, 60: 174–176, 1984.
31.
YasargilM.G.: Microneurosurgery, GT Verlag, New York, 1993.
32.
De Angelis: Primary central nervous system lymphoma imitates multiple sclerosis. J Neurooncol, 9: 177–181, 1990.
33.
ReniM., FerreriA.J.M., ZoldmanM.C., VillaE.: Primary brain lymphomas in patients with a prior or concomitant malignancy. J Neuroncol, 32: 135–142, 1997.
34.
CunyE., LiseauH., CohadonF.: Lymphomes primitifs du sisteme nerveux central. Role diagnostique des remission cortico-induites. Neurochirurgie, 44: 19–24, 1998.
35.
TomlinsonF.H., KurtinP.J., SumanV.J., ScheithauerB.W., O’ FallonJ.R., KellyP.J., JackC.R.Jr., O'NeillB.P.: Primary intracerebral malignant lymphoma: a clinicopathological study of 89 patients. J Neurosurg, 82: 558–566, 1995.
36.
PollackI.A., LunsfordL.D., FlickingerJ.C., Dame ShekH.L.: Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer, 63: 939–947, 1989.
37.
De AngelisL.M.: Current management of primary central nervous system lymphoma. Oncology, 9: 155–169, 1995.
38.
BogdahnU., BogdahnS., MertensH.G., DommashD., WodarzR., WunshP.H., KuhlP., RichterE.: Primary non-Hodgkin's lymphomas of the CNS. Acta Neurol Scand, 73: 602–614, 1986.
39.
HochbergF.H., MillerD.C.: Primary central nervous system lymphoma. J Neurosurg, 68: 835–853, 1988.
40.
HenryJ.M., HeffnerR.R.Jr., DillardS.H., EearleK.M., DavisR.L.: Primary malignant lymphomas of the central nervous system. Cancer, 34: 1293–1302, 1974.
41.
FineH.A., MayerR.J.: Primary central nervous system lymphoma. Ann Intern Med, 119: 1093–1104, 1993.
42.
GrantJ.W., von DeimlingA.: Primary T-cell lymphoma of the central nervous system. Arch Pathol Lab Med, 114: 24–27, 1990.
43.
HelleT.L., BrittR.H., ColbyT.V.: Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford. J Neurosurg, 60: 94–103, 1984.
44.
SchaumburgH.H., PlankC.R., AdamsR.D.: The reticulum cells sarcoma-microglioma group of brain tumors. A consideration their clinical features and therapy. Brain, 95: 199–212, 1972.
45.
WoodmanR., ShinK., PineoG.: Primary non-Hodgkin's lymphoma of the brain: a review. Medicine, 64: 425–430, 1985.
46.
FineH.A.: Treatment of primary central nervous system lymphoma: still more questions than answers. Blood, 86: 2873–2875, 1995.
47.
NelsonD.F., MartzK.L., BonnerH., NelsonJ.S., NewallJ., KermanH.D., ThomsonJ.W., MurrayK.J.: Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the radiation therapy oncology group (RTOG): RTOG 8315. Int J Radiot Oncol Biol Phys, 2: 9–17, 1992.
48.
FreilichR.J., De AngelisL.M.: Primary central nervous system lymphoma. Neurol Clin, 13: 901–914, 1995.
49.
FineH.A., MayerR.J.: Primary central nervous system lymphoma. Ann Intern Med, 119: 1093–1104, 1993.
50.
De AngelisL.M., YahalomJ., ThalerH., KherU.: Combined modality therapy for primary CNS lymphoma. J Clin Oncol, 10: 635–643, 1992.
51.
GlassJ., GruberM.L., CherL., HochbergF.H.: Pre-irradiation methrotrexate chemotherapy of primary central nervous system lymphoma. Long-term outcome. J Neurosurg, 81: 188–195, 1992.
52.
FreilichR.J., DelattreJ.Y., MonjourA., De AngelisL.M.: Chemotherapy without radiation therapy for initial treatment of primary CNS lymphoma in older patients. Neurology, 46: 435–439, 1996.
